NEW YORK, NY / ACCESSWIRE / April 10, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc.("iRhythm" or the "Company") ( IRTC ). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/irtc .
The investigation concerns whether iRhythmand certain of its officers and/or directors have violated federal securities laws.
Between March 13, 2019 and March 27, 2019, several analysts and reports were concerned about: (1) the sustainability of third-party reimbursements to iRhythm attributable to sales of its Zio XT Extended Holter patch device; (2) whether the company's statements about the total addressable market for iRhythm products may have been misleading; and (3) if iRhythm employed misleading accounting techniques to stretch revenue and manage bad debt expense.
If you are aware of any facts relating to this investigation, or purchased iRhythm shares,you can assist this investigation by visiting the firm's site: www.bgandg.com/irtc . You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View source version on accesswire.com: